Table 2. Frequency of description of design elements and design element options in the two preclinical datasets evaluated (CAMARADES (brain trauma/stroke) and toxicology).
| Design element | Element options | CAMARADES N = 100 |
Toxicology N = 100 |
|---|---|---|---|
| Control group | None | 0 | 0 |
| Concurrent | 98 | 92 | |
| Historic | 0 | 0 | |
| Unclear | 2 | 8 | |
| Unit of concern | Group | 0 | 12 |
| Individual | 92 | 37 | |
| Nested | 0 | 17 | |
| Unclear | 8 | 34 | |
| Arrangement of the factors | Complete factorial | 27 | 42 |
| Cross-over | 0 | 0 | |
| Incomplete factorial | 12 | 11 | |
| Parallel | 58 | 24 | |
| Split-Plot | 0 | 20 | |
| Unclear | 3 | 3 | |
| Allocation | Haphazard | 0 | 0 |
| Minimization | 0 | 0 | |
| Random | 79 | 62 | |
| Systematic | 0 | 0 | |
| Unclear | 21 | 38 | |
| Concealment (a) | Intervention allocation | 12 | 0 |
| NDD* | 88 | 100 | |
| Concealment (b) | Outcome assessment | 60 | 12 |
| NDD* | 40 | 88 | |
| Independence (a) | Pseudo-replication | 44 | 50 |
| NDD* | 56 | 50 | |
| Independence (b) | Repeated measures | 40 | 59 |
| NDD* | 60 | 41 | |
| Investigator-identified study design | Provided | 0 | 7 |
| NDD* | 100 | 93 | |
| Nature of the factors | All could be randomized | 94 | 69 |
| Some could be randomized | 5 | 30 | |
| None could be randomized | 0 | 0 | |
| Unclear | 1 | 1 |
* NDD = no discernable description: neither reviewer/reader was able to find text that described this element.